Siegel is Chief Executive Officer at AFFiRiS since March 2015. He is responsible for operations, including clinical operations, finance and administration at AFFiRiS. Prior to joining AFFiRiS as Chief Operating Officer in 2014, Oliver was Managing Director and Head of Pharmaceuticals at leading Investment Bank NM Rothschild & Sons, London. He has more than 15 years of experience in leading Investment Banks Rothschild, HSBC, Merrill Lynch and Deutsche Bank on strategy and fundraising for Pharma, Biotechnology and Healthcare Services companies. Oliver holds a degree in business administration from Otto-Friedrich-University Bamberg.